Early research (Phase 1)Study completedNCT02902237What this trial is testingTTF-NGR Phase I StudyWho this might be right forMalignant Solid TumorsLymphomas University Hospital Muenster 24
Early research (Phase 1)Ended earlyNCT01769222What this trial is testingIpilimumab and Local Radiation for Selected Solid TumorsWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more Stanford University 3
Early research (Phase 1)Study completedNCT00101270What this trial is testingOxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasWho this might be right forChildhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT03291938What this trial is testingIACS-010759 in Advanced CancersWho this might be right forAdvanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+22 more M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT02512926What this trial is testingCarfilzomib in Combination With Cyclophosphamide and Etoposide for ChildrenWho this might be right forRelapsed Solid TumorsRefractory Solid TumorsRelapsed Leukemia+1 more Stanford University 4
Not applicableUnknownNCT05438342What this trial is testingAn Expanded Clinical Study of Triple Therapy for Refractory Solid Tumors That Failed First-line Treatment for Recurrence and MetastasisWho this might be right forAdvanced CancerMetastatic Cancer Shanghai Pudong Hospital 195
Early research (Phase 1)Study completedNCT00003144What this trial is testingChemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid TumorsWho this might be right forDrug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific NYU Langone Health 44
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Testing effectiveness (Phase 2)Ended earlyNCT00949117What this trial is testingCyproheptadine Hydrochloride and Nutritional Supplementation in Treating Young Patients With Weight Loss With CancerWho this might be right forLeukemiaLymphomaMalnutrition+3 more University of South Florida 9
Not applicableStudy completedNCT00005881What this trial is testingQuality of Life in Children Treated for CancerWho this might be right forLeukemiaLymphomaUnspecified Childhood Solid Tumor, Protocol Specific Children's Oncology Group 538
Early research (Phase 1)Study completedNCT00036790What this trial is testingMotexafin Gadolinium and Doxorubicin in Treating Patients With Advanced CancerWho this might be right forBreast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more University of Wisconsin, Madison
Early research (Phase 1)Study completedNCT02159989What this trial is testingSapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryWho this might be right forAdvanced Malignant Solid NeoplasmFibrolamellar CarcinomaMetastatic Malignant Solid Neoplasm+5 more National Cancer Institute (NCI) 83
Testing effectiveness (Phase 2)UnknownNCT04458389What this trial is testingTY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory LymphomasWho this might be right forLocally Advanced /Metastatic Solid TumorsRelapsed or Refractory Lymphomas Tayu Huaxia Biotech Medical Group Co., Ltd. 268
Early research (Phase 1)Study completedNCT00003082What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Advanced CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+4 more University of Arizona 27
Testing effectiveness (Phase 2)Study completedNCT00416624What this trial is testingEpoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by ChemotherapyWho this might be right forAnemiaLeukemiaLymphoma+4 more Mayo Clinic 239
Testing effectiveness (Phase 2)Looking for participantsNCT05958121What this trial is testingIMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid TumorsWho this might be right forRefractory CancerRecurrent CancerSolid Tumor, Adult+1 more Immatics Biotechnologies GmbH 145
Testing effectiveness (Phase 2)Ended earlyNCT03323398What this trial is testingDose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced MalignanciesWho this might be right forRelapsed/Refractory Solid Tumor Malignancies or LymphomaOvarian Cancer ModernaTX, Inc. 79
Early research (Phase 1)Study completedNCT00005021What this trial is testingCombination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific Fox Chase Cancer Center 17
Testing effectiveness (Phase 2)Study completedNCT03213678What this trial is testingSamotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmAnn Arbor Stage III Non-Hodgkin LymphomaAnn Arbor Stage IV Non-Hodgkin Lymphoma+30 more National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Ended earlyNCT02963610What this trial is testingPhase I/II Study of Lenalidomide Plus Pembrolizumab in Patients With Solid Tumors With Expansion in Non-small Cell Lung CancerWho this might be right forRelapsed or Refractory Solid TumorsNonsmall Cell Lung Cancer Fox Chase Cancer Center 3